Navigation Links
Nycomed to Accelerate Expansion in China Through Acquisition of Majority Stake in Guangdong Techpool Bio-Pharma
Date:11/1/2010

h joint venture specialized in research, development, manufacturing and marketing of biologic drugs. It is a pioneer in China in terms of development and production of drugs from natural sources.

As a leading manufacturer of human urinary protein-based drugs, Techpool has a strong intellectual property portfolio, with 35 patents filed, of which 17 have been approved including one in the US. With its proprietary biological separation and purification technologies, Techpool has undergone three major R&D transformations from "generics" to "generics and innovation" to "innovation". Its focus on and investment in innovative drug development has allowed Techpool to undertake six national science and technology projects as well as dozens of provincial and municipal science and technology projects. Techpool has also developed and launched a series of innovative protein drugs, noticeably Kailikang® (Kallikrein for injection), Techpool Roan® (Ulinastatin for injection) and Roxin® (Urokinase for injection). Additionally, Techpool has introduced several state-of-the-art production lines that meet EU EMA and US FDA standards to produce lyophilized injections, parenteral injections and Active Pharmaceutical Ingredients.

While focusing on R&D and commercialization of new products, Techpool aggressively pursues a marketing strategy of building brands through academic promotions. It has established a marketing network covering the entire country of China and its products are currently distributed throughout Japan, South Korea, India and Pakistan, among many other countries, achieving rapid expansion in China and steady growth internationally.

About Nycomed

Nycomed is a privately owned global pharmaceutical company with a differentiated portfolio focused on branded medicines in gastroenterology, respiratory and inflammatory diseases, pain, osteoporosis and tissue management. An extensive range of OTC products completes the portfolio
'/>"/>

SOURCE Nycomed
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Steve Andrzejewski Joins Nycomed US Inc.
2. Nycomeds U.S. Patent for Protonix(R) (pantoprazole) Valid
3. DURECT and Nycomed Amend POSIDUR(TM) License Agreement to Separate Funding and Control of U.S. and E.U. Clinical Programs and to Expand Territory
4. Micromet and Nycomed Begin Formal Preclinical Safety Studies for Antibody MT203 for Inflammatory and Autoimmune Diseases
5. Samplifys New Medical Ultrasound Development Kit Accelerates Equipment Time to Market By Up to 12 Months
6. Hanger Orthopedic Group Signs Definitive Merger Agreement To Acquire Accelerated Care Plus
7. New IonWorks Barracuda Automated Patch Clamp System Meets Need for Affordable, Accelerated Screening of Ligand- & Voltage-Gated Ion Channels Via Direct Electrophysiology Assays
8. HydroCision Announces New Investment to Accelerate Growth of Novel Fluidjet Technology for Minimally Invasive Spine Surgery
9. Diaceutics and London Genetics Partner to Accelerate Biomarker Development in the Global Biopharmaceutical Industry
10. Reportlinker Adds Clinical Trial Patient Recruitment: Accelerate Enrollment, Increase Retention and Reduce Costs
11. Cetero Research Launches Seminar Series on Accelerated Proof-of-Concept in Drug Development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2015)... --NOWDiagnostics Inc., based in Springdale, Ark. , ... Canada , a move that brings the company ... have greater access to information concerning their health. ... blood-based rapid tests that allow health care providers to ... ailments and diseases. ZBx Corporation, a Toronto ...
(Date:9/1/2015)... , Sept. 1, 2015  Dr. Cindy ... Labs , the cannabis testing subsidiary of DigiPath, Inc. ... Group about the lack of consistency in today,s ... online resource for medical cannabis information, she explained that ... because their lack of uniform requirements makes standardization impossible. ...
(Date:9/1/2015)... 1, 2015   Alpha Imaging LLC , a leading distributor ... announced today that they have been awarded exclusive rights to ... in Michigan.   The new territory supplements Alpha Imaging,s existing Shimadzu sales ... Ohio , Indiana , ... , West Virginia , Delaware ...
Breaking Medicine Technology:NOWDiagnostics Inc. Acquires Canada's ZBx Corporation 2NOWDiagnostics Inc. Acquires Canada's ZBx Corporation 3DigiPath Labs CSO Dr. Cindy Orser Calls for Uniform Standards for Cannabis Safety Testing 2DigiPath Labs CSO Dr. Cindy Orser Calls for Uniform Standards for Cannabis Safety Testing 3Alpha Imaging Expands Shimadzu Territory 2
... Medical Systems (NYSE: VAR ) today announced that ... N.A. to repurchase $250 million of its common stock under ... revolving credit facility with Bank of America, N.A. to increase ... Under the accelerated repurchase agreement, Varian will pay $250 ...
... Boehringer Ingelheim Pharmaceuticals, Inc. (BIPI) today announced ... trial evaluating the safety and pharmacokinetics of dabigatran ... valves.(1) The 12-week study will compare three doses ... 300mg bid) to warfarin in patients with both ...
Cached Medicine Technology:Varian Medical Systems Announces $250 Million Accelerated Stock Repurchase; Increases Its Revolving Credit Facility 2Varian Medical Systems Announces $250 Million Accelerated Stock Repurchase; Increases Its Revolving Credit Facility 3Boehringer Ingelheim to Launch RE-ALIGN™ Trial to Evaluate Dabigatran Etexilate in Patients with Mechanical Heart Valves 2Boehringer Ingelheim to Launch RE-ALIGN™ Trial to Evaluate Dabigatran Etexilate in Patients with Mechanical Heart Valves 3Boehringer Ingelheim to Launch RE-ALIGN™ Trial to Evaluate Dabigatran Etexilate in Patients with Mechanical Heart Valves 4Boehringer Ingelheim to Launch RE-ALIGN™ Trial to Evaluate Dabigatran Etexilate in Patients with Mechanical Heart Valves 5Boehringer Ingelheim to Launch RE-ALIGN™ Trial to Evaluate Dabigatran Etexilate in Patients with Mechanical Heart Valves 6Boehringer Ingelheim to Launch RE-ALIGN™ Trial to Evaluate Dabigatran Etexilate in Patients with Mechanical Heart Valves 7
(Date:9/1/2015)... ... 2015 , ... Georgia State University and its partners have ... stemming sexual assaults on their campuses. , The free, evidence-based survey was developed ... researchers and student affairs professionals responding to calls by the Obama Administration to ...
(Date:9/1/2015)... ... September 01, 2015 , ... ... Splashtop Business for Remote Support , a solution optimized for MSPs and IT ... the escalating renewal prices and inadequate customer services of existing remote support solution, ...
(Date:9/1/2015)... , ... September 01, 2015 , ... ... Clinic, ranked a top-five hospital by U.S. News & World Report, to provide ... patients. , Editorial and marketing groups within OncLive, which provides oncologists resources ...
(Date:9/1/2015)... ... September 01, 2015 , ... With former IBMers among ... Math) disciplines since its inception more than 35 years ago. A pilot program begun ... their teachers - and, not just those intent on pursuing careers in these fields. ...
(Date:9/1/2015)... ... 01, 2015 , ... Zecurion, a leading developer of data loss prevention solutions, ... endpoint DLP developed specifically for Mac OS. , In June 2015, the company successfully ... information security professionals had participated. The beta test done by the developer community enabled ...
Breaking Medicine News(10 mins):Health News:Georgia State, Partners Introduce Climate Survey to Aid in Preventing Campus Sexual Assaults 2Health News:Splashtop Launches Splashtop Business for Remote Support, the Simple, Reliable, and Cost-Effective Solution for MSPs and IT Professionals 2Health News:Splashtop Launches Splashtop Business for Remote Support, the Simple, Reliable, and Cost-Effective Solution for MSPs and IT Professionals 3Health News:Splashtop Launches Splashtop Business for Remote Support, the Simple, Reliable, and Cost-Effective Solution for MSPs and IT Professionals 4Health News:OncLive® and Cleveland Clinic Team up to Provide News, Information About Cancer Research and Patient Care 2Health News:OncLive® and Cleveland Clinic Team up to Provide News, Information About Cancer Research and Patient Care 3Health News:Inmar Announces Program to Fuel Student Passion for STEM – with an Unconventional Twist 2Health News:Zecurion Announces Endpoint Security for Mac 2
... survival is associated with increased risk of long-term abnormalities ... July 26 issue of Archives of Internal Medicine ... background in the article, childhood cancer survival rates have ... 70 to 80 percent currently. The authors also note ...
... grow, but the increased wealth has done little to ... at the University of California, Berkeley. They say the ... mental health and well-being, and are seeking to correct ... China. As part of that effort, UC Berkeley ...
... UT Southwestern Medical Center have uncovered the biological rationale ... several weeks may help individuals with lupus, a chronic ... in the U.S. Unlike the ... muscle, corticosteroids are routinely used to treat inflammation in ...
... , MONDAY, July 26 (HealthDay News) -- Recent reports questioning ... people may shun the very products that could save their ... these allegations -- that many topical sunscreens can cause skin ... and is dubious at best, said Dr. Jeffrey Dover, president ...
... By Steven Reinberg HealthDay Reporter , MONDAY, July ... and other "medical devices" send more than 70,000 American children ... "The device injury rate among the kids were driven by ... Cunlin Wang, a medical epidemiologist in the Office of Surveillance ...
... target the protein mTOR are used to treat several forms ... A team of researchers, led by Alberto Bardelli, at the ... way to help predict which patients will respond to such ... with mutations in the PIK3CA gene responded to everolimus in ...
Cached Medicine News:Health News:Childhood cancer survivors may have abnormal long-term cardiac function 2Health News:UC Berkeley psychologists bring science of happiness to China 2Health News:UC Berkeley psychologists bring science of happiness to China 3Health News:UC Berkeley psychologists bring science of happiness to China 4Health News:Researchers uncover biological rationale for why intensive lupus treatment works 2Health News:Researchers uncover biological rationale for why intensive lupus treatment works 3Health News:Sunscreen Concerns Unfounded, Experts Say 2Health News:Sunscreen Concerns Unfounded, Experts Say 3Health News:More Than 70,000 Kids Injured By Medical Devices Each Year 2
... a whole blood hematology control manufactured specifically ... 120, and the Coulter AcT5diff instruments. The ... white cell differential, positioning the populations within ... systems. The product offers 105-day closed-vial stability ...
... assayed hematology control, offers complete assay values ... with the Coulter GENS, STKS, MAXM and ... stability, 105-day closed-vial stability and is available ... 4.0ml pierceable cap vial is compatible with ...
Abiomed introduces its new intra-aortic balloon (IAB); an easy-to-insert, minimally invasive technology designed to enhance blood flow to the heart and other organs for patients with diminished heart...
Diagnosoft HARP is designed for rapid analysis of tagged cardiac MR images using the HARP technology, which is packaged into an intuitive, easy-to-use graphic user interface....
Medicine Products: